GlassScriptPhysician profile
Sunita Gaba
NPI 1508899725
$3,549.16
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,909 · 2020: $633 · 2021: $385 · 2022: $623.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $578.41 | 2019-2022 | |
| Amgen INC. | $477.67 | 2019-2022 | |
| Glaxosmithkline, LLC. | $352.37 | 2019-2022 | |
| Lilly USA, LLC | $294.35 | 2019-2020 | |
| Daiichi Sankyo INC. | $229.23 | 2019-2022 | |
| Pfizer INC. | $228.81 | 2019-2022 | |
| Novo Nordisk INC | $223.41 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $192.58 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $153.08 | 2019 | |
| Nestle Healthcare Nutrition INC. | $99.83 | 2021-2022 | |
| Astellas Pharma US INC | $83.31 | 2019-2020 | |
| Abbvie INC. | $58.27 | 2021-2022 | |
| Amarin Pharma, INC. | $57.76 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $54.85 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $50.64 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $41.69 | 2021-2022 | |
| Mylan Specialty L.P. | $40.39 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.05 | 2021 | |
| Allergan, INC. | $36.49 | 2020 | |
| Novartis Pharmaceuticals Corporation | $36.05 | 2019 | |
| Sanofi-Aventis U.S. LLC | $33.27 | 2021-2022 | |
| Antares Pharma, INC. | $25.53 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.49 | 2022 | |
| Avanir Pharmaceuticals, INC. | $25.43 | 2019 | |
| Sunovion Pharmaceuticals INC. | $23.07 | 2019 | |
| Bausch Health US, LLC | $22.47 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.19 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.51 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.67 | 2020 | |
| Currax Pharmaceuticals LLC | $12.47 | 2022 | |
| Hikma Pharmaceuticals USA | $10.82 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunita Gaba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.